Health services research (patient navigator) for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Ohio State University Comprehensive Cancer Center, Columbus, OHBreast Cancer+19 MorePatient Navigation - Behavioral
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is testing a navigation program to help Black breast cancer survivors access physical, emotional, and nutritional support and improve their quality of life.

Eligible Conditions
  • Stage IIA Breast Cancer
  • Stage III Breast Cancer
  • Stage IIB Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage 1 Breast Cancer
  • Stage IA Breast Cancer
  • Stage 2 Breast Cancer
  • Stage II Breast Cancer
  • Stage IB Breast Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Anhydrous Enol-oxaloacetate
1
Caffeine anhydrous 5% added to Lipoderm Cream Base.
1
Patient navigator

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: Up to 6 months

Up to 6 months
Breast Cancer Self Efficacy Scale score
Consent rate
Dropout rate
European Organization for Research and Treatment of Cancer Quality of Life-30 score
Patient-Reported Outcomes Measurement Information System score
Recruitment rate

Trial Safety

Safety Progress

1 of 3

Similar Trials

2
Anhydrous Enol-oxaloacetate
2
Caffeine anhydrous 5% added to Lipoderm Cream Base.
1
Patient navigator

Trial Design

1 Treatment Group

Health services research (patient navigator)
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Health services research (patient navigator) · No Placebo Group · N/A

Health services research (patient navigator)Experimental Group · 3 Interventions: Patient Navigation, Questionnaire Administration, Quality-of-Life Assessment · Intervention Types: Behavioral, Other, Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2019
Completed Phase 2
~38320

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 6 months

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
290 Previous Clinical Trials
286,099 Total Patients Enrolled
22 Trials studying Breast Cancer
2,829 Patients Enrolled for Breast Cancer
Bridget A Oppong, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Eligibility Criteria

Age 18+ · Female Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a black woman over 18 years old who has breast cancer in the early to intermediate stages (stage I-III).
References

Frequently Asked Questions

Are physicians currently recruiting volunteers for this medical experiment?

"According to the details provided by clinicaltrials.gov, this research initiative is actively recruiting participants. It was publicly announced on November 14th 2022 and last updated on December 21st 2022." - Anonymous Online Contributor

Unverified Answer

What is the scope of participation in this research endeavor?

"Affirmative. Clinicaltrials.gov's data suggests that this clinical trial, initially posted on November 14th 2022, is recruiting participants. Approximately 40 individuals must be recruited from 1 medical site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top